Stocks
Arena Pharmaceuticals (ARNA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.29 | 3.02 | -1.34 | 2.67 | 0.84 | 0.84 | |||
| Changes by years, y/y, % | -40% | +32% | -144% | -300% | -69% | -26.2% | |||
Arena Pharmaceuticals. Debt/EBITDA
Arena Pharmaceuticals. Debt/EBITDA, changes, %
Arena Pharmaceuticals (ARNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | LTM ? | |||
| Debt/EBITDA | 2.61 | 2.49 | 1.95 | 1.27 | 0.84 | 0.84 | ||
| Changes by years, y/y, % | -286% | +14% | -37% | -57% | -68% | |||
| Changes by quarters, q/q, % | -12% | -5% | -22% | -35% | -34% | |||
